Stocks and Investing
Stocks and Investing
Thu, February 18, 2021
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
[ Thu, Feb 18th 2021
] - WOPRAI
Wed, February 17, 2021
[ Wed, Feb 17th 2021
] - WOPRAI
[ Wed, Feb 17th 2021
] - WOPRAI
Serge Belanger Maintained (VRCA) at Strong Buy with Increased Target to $22 on, Feb 17th, 2021
Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $17 to $22 on, Feb 17th, 2021.
Serge, nor any peers, have made any analyst calls on VRCA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources